Other | ||||||||||||||||||||||||||||||
RMJ. 2013; 38(2): 188-189 Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics Muhammad Asif Qureshi.
|
How to Cite this Article |
Pubmed Style Muhammad Asif Qureshi. Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. RMJ. 2013; 38(2): 188-189. Web Style Muhammad Asif Qureshi. Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. https://www.rmj.org.pk/?mno=30285 [Access: December 05, 2023]. AMA (American Medical Association) Style Muhammad Asif Qureshi. Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. RMJ. 2013; 38(2): 188-189. Vancouver/ICMJE Style Muhammad Asif Qureshi. Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. RMJ. (2013), [cited December 05, 2023]; 38(2): 188-189. Harvard Style Muhammad Asif Qureshi (2013) Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. RMJ, 38 (2), 188-189. Turabian Style Muhammad Asif Qureshi. 2013. Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. Rawal Medical Journal, 38 (2), 188-189. Chicago Style Muhammad Asif Qureshi. "Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics." Rawal Medical Journal 38 (2013), 188-189. MLA (The Modern Language Association) Style Muhammad Asif Qureshi. "Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics." Rawal Medical Journal 38.2 (2013), 188-189. Print. APA (American Psychological Association) Style Muhammad Asif Qureshi (2013) Autoimmunity under the umbrella of “Danger Model”: new insights into tolerance, rejection and autoimmune therapeutics. Rawal Medical Journal, 38 (2), 188-189. |